Best matches for Prünte C[Author]:

Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study. Prünte C et al. Br J Ophthalmol. (2016)

[Not Available]. Prünte C et al. Ther Umsch. (2016)

ASSESSMENT OF DRUSEN AND OTHER RETINAL DEGENERATIVE CHANGES IN PATIENTS WITH HEREDITARY HEMOCHROMATOSIS. Menghini M et al. Retina. (2018)

  • History not found.

Supplemental Content

Loading ...
Support Center